Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Change in Acquisitions & Divestments (2020 - 2025)

Historic Change in Acquisitions & Divestments for Nurix Therapeutics (NRIX) over the last 6 years, with Q4 2025 value amounting to $179.8 million.

  • Nurix Therapeutics' Change in Acquisitions & Divestments rose 1273.46% to $179.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was $617.5 million, marking a year-over-year increase of 3439.08%. This contributed to the annual value of $617.5 million for FY2025, which is 3439.08% up from last year.
  • According to the latest figures from Q4 2025, Nurix Therapeutics' Change in Acquisitions & Divestments is $179.8 million, which was up 1273.46% from $156.2 million recorded in Q3 2025.
  • Over the past 5 years, Nurix Therapeutics' Change in Acquisitions & Divestments peaked at $179.8 million during Q4 2025, and registered a low of $41.0 million during Q1 2023.
  • For the 5-year period, Nurix Therapeutics' Change in Acquisitions & Divestments averaged around $95.9 million, with its median value being $88.8 million (2022).
  • Per our database at Business Quant, Nurix Therapeutics' Change in Acquisitions & Divestments soared by 118008.37% in 2021 and then tumbled by 3023.25% in 2023.
  • Nurix Therapeutics' Change in Acquisitions & Divestments (Quarter) stood at $55.0 million in 2021, then soared by 53.54% to $84.5 million in 2022, then decreased by 9.33% to $76.6 million in 2023, then soared by 108.21% to $159.5 million in 2024, then rose by 12.73% to $179.8 million in 2025.
  • Its last three reported values are $179.8 million in Q4 2025, $156.2 million for Q3 2025, and $142.3 million during Q2 2025.